LASOFOXIFENE TARTRATE

LASOFOXIFENE TARTRATE

Biochem/physiol Actions

Lasofoxifene possesses strong resistance to intestinal wall glucuronidation and thus promotes oral bioavailability. In postmenopausal women, it reduces bone resorption, bone loss and low density lipoprotein (LDL) cholesterol. Selective and regular dose of Lasofoxifene is known to reduce the risk of fractures, breast cancer, major coronary heart disease, and stroke.

Lasofoxifene is a third-generation selective estrogen receptor modulator (SERM).

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3574372 LASOFOXIFENE TARTRATE white to beige 100 INEHJXCWEVNEDZ-LUDNRVPPSA-N 1S/C28H31NO2.C4H6O6/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29;5-1(3(7)8)2(6)4(9)10/h1-3,6-9,11-13,15, SIGMA-ALDRICH DMSO: 10 mg/mL, clear powder ≥98% (HPLC)
£138.73 (exc VAT) per 10MG
-
+
3574373 LASOFOXIFENE TARTRATE white to beige 100 INEHJXCWEVNEDZ-LUDNRVPPSA-N 1S/C28H31NO2.C4H6O6/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29;5-1(3(7)8)2(6)4(9)10/h1-3,6-9,11-13,15, SIGMA-ALDRICH DMSO: 10 mg/mL, clear powder ≥98% (HPLC)
£551.57 (exc VAT) per 50MG
-
+